Bibliography:

  1. ‘psychiatry’ tag

  2. ‘modafinil’ tag

  3. ‘psychedelics’ tag

  4. ‘lithium-in-water’ tag

  5. ‘psych of nature’ tag

  6. ‘neuroscience’ tag

  7. ‘willpower’ tag

  8. ‘RL exploration’ tag

  9. ‘scientific bias’ tag

  10. ‘sleep’ tag

  11. Why To Not Write A Book

  12. Why Do Obesity Drugs Seem to Treat so Many Other Ailments?

  13. The genetic architecture of dog ownership: large-scale genome-wide association study in 97,552 European-ancestry individuals

  14. Genetic influences on depression and selection into adverse life experiences

  15. Fraudulent studies are undermining the reliability of systematic reviews—a study of the prevalence of problematic images in preclinical studies of depression

  16. Associations between common genetic variants and income provide insights about the socioeconomic health gradient

  17. The Economic Impact of Depression Treatment in India: Evidence from Community-Based Provision of Pharmacotherapy

  18. Persistent thinness and anorexia nervosa differ on a genomic level

  19. Characterizing the phenotypic and genetic structure of psychopathology in UK Biobank

  20. Decline in Independent Activity As a Cause of Decline in Children’s Mental Well-Being: Summary of the Evidence

  21. Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood

  22. Magic Mushrooms. LSD. Ketamine. The Drugs That Power Silicon Valley

  23. Enhanced amygdala-cingulate connectivity associates with better mood in both healthy and depressive individuals after sleep deprivation

  24. Longitudinal follow-up of subsequent psychiatric comorbidities among children and adolescents with autism spectrum disorder

  25. Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients

  26. Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test

  27. Common and rare variant associations with latent traits underlying depression, bipolar disorder, and schizophrenia

  28. Relationship of Family Genetic Risk Score With Diagnostic Trajectory in a Swedish National Sample of Incident Cases of Major Depression, Bipolar Disorder, Other Non-affective Psychosis, and Schizophrenia

  29. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients

  30. Phenotype integration improves power and preserves specificity in biobank-based genetic studies of MDD

  31. Physical Activity Interventions to Alleviate Depressive Symptoms in Children and Adolescents: A Systematic Review and Meta-analysis

  32. The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase

  33. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomized clinical trial

  34. Identification of Novel, Replicable Genetic Risk Loci for Suicidal Thoughts and Behaviors Among US Military Veterans

  35. A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability

  36. In-Person Schooling and Youth Suicide: Evidence from School Calendars and Pandemic School Closures

  37. Genomic Structural Equation Modeling Reveals Latent Phenotypes in the Human Cortex with Distinct Genetic Architecture

  38. The Paradox of Wealthy Nations’ Low Adolescent Life Satisfaction

  39. Stress-Induced Mucosal Layer Disruption Drives Gut Dysbiosis and Depressive-like Behaviors

  40. Association between meatless diet and depressive episodes: A cross-sectional analysis of baseline data from the longitudinal study of adult health (ELSA-Brasil)

  41. Sadder ≠ Wiser: Depressive Realism is not Robust to Replication

  42. On the Randomness of Suicide: An Evolutionary, Clinical Call to Transcend Suicide Risk Assessment

  43. Identification of 64 new risk loci for major depression, refinement of the genetic architecture and risk prediction of recurrence and comorbidities

  44. Genome-wide association study meta-analysis of suicide attempt in 43,871 cases identifies twelve genome-wide statistically-significant loci

  45. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

  46. Multi-ancestry GWAS of major depression aids locus discovery, fine-mapping, gene prioritization, and causal inference

  47. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial

  48. The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients

  49. Effectiveness and cost-effectiveness of universal school-based mindfulness training compared with normal school provision in reducing risk of mental health problems and promoting well-being in adolescence: the MYRIAD cluster randomized controlled trial

  50. Is an elevated family-genetic risk for major psychiatric disorders specific to creative occupations?

  51. Taking a One-Week Break from Social Media Improves Well-Being, Depression, and Anxiety: A Randomized Controlled Trial

  52. Increased global integration in the brain after psilocybin therapy for depression

  53. Suicides of Psychologists and Other Health Professionals: National Violent Death Reporting System Data, 2003–2018

  54. Genetic variants associated with longitudinal changes in brain structure across the lifespan

  55. Exome-wide screening identifies novel rare risk variants for major depression disorder

  56. Peers’ Private Tutoring and Adolescent Depressive Symptoms: Quasi-Experimental Evidence From Secondary Schools in South Korea

  57. Social media use and its impact on adolescent mental health: An umbrella review of the evidence

  58. Genetics, leadership position, and well-being: An investigation with a large-scale GWAS

  59. Sex-specific genetic and transcriptomic liability to neuroticism

  60. Modeling assortative mating and genetic similarities between partners, siblings, and in-laws

  61. Electroconvulsive Therapy

  62. Sleep duration and brain structure—phenotypic associations and genotypic covariance

  63. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains

  64. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

  65. A multi-pronged investigation of option generation using depression, PET and modafinil

  66. Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study

  67. Myths and misconceptions about personality traits and tests

  68. Structure-based discovery of non-hallucinogenic psychedelic analogs

  69. Mental health in people with minority sexual orientations: A meta-analysis of population-based studies

  70. The impact of early stages of COVID-19 on the mental health of autistic adults in the United Kingdom: A longitudinal mixed-methods study

  71. Increased depressive and anxiety symptoms in non-heterosexual individuals: Moderation by childhood factors using a twin design

  72. Association Between Homeschooling and Adolescent Sleep Duration and Health During COVID-19 Pandemic High School Closures

  73. A systematic review and meta-analysis of the success of blinding in antidepressant RCTs

  74. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses

  75. Gastrointestinal Interoception in Eating Disorders: Charting a New Path

  76. Glucagon-like Peptide 1 Receptor Activation Inhibits Microglial Pyroptosis via Promoting Mitophagy to Alleviate Depression-like Behaviors in Diabetic Mice

  77. Parents think—incorrectly—that teaching their children that the world is a bad place is likely best for them

  78. Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth

  79. More treatment but no less depression: The Treatment-Prevalence Paradox

  80. Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials

  81. What doesn’t kill her, will make her depressed

  82. Deletion of Loss-of-Function-Intolerant Genes and Risk of 5 Psychiatric Disorders

  83. Vicious cycle of emotional maltreatment and bullying perpetration/victimization among early adolescents: Depressive symptoms as a mediator

  84. Comparing Copy Number Variations in a Danish Case Cohort of Individuals With Psychiatric Disorders

  85. Psychedelics alter metaphysical beliefs

  86. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers

  87. Largest psilocybin trial finds the psychedelic is effective in treating serious depression

  88. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

  89. Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders

  90. Sex impacts the function of major depression-linked variants in vivo

  91. Like this meta-analysis: Screen media and mental health

  92. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials

  93. Global urbanicity is associated with brain and behavior in young people

  94. Uncovering the Genetic Architecture of Broad Antisocial Behavior through a Genome-Wide Association Study Meta-analysis.

  95. Meat and mental health: A meta-analysis of meat consumption, depression, and anxiety

  96. Major Depressive Disorder and Lifestyle: Correlated Genetic Effects in Extended Twin Pedigrees

  97. Investigating perceived heritability of mental health disorders and attitudes toward genetic testing in the United States, United Kingdom, and Australia

  98. Do Racial Differences in Coping Resources Explain the Black-White Paradox in Mental Health? A Test of Multiple Mechanisms

  99. Lithium can mildly increase health during ageing but not lifespan in mice

  100. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

  101. Polygenic Heterogeneity Across Obsessive-Compulsive Disorder Subgroups Defined by a Comorbid Diagnosis

  102. Relationship between rice farming and polygenic scores potentially linked to agriculture in China

  103. Psychedelic Drugs and Atheism: Debunking the Myths

  104. Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention deficit hyperactivity disorder

  105. The prevalence of mental disorders among homeless people in high-income countries: An updated systematic review and meta-regression analysis

  106. Mental Healthcare Usage of Transgender Youth Before and After Affirming Treatment

  107. Genome-wide association meta-analysis of childhood and adolescent internalizing symptoms

  108. Cognitive Behavior Therapy for Depression From an Evolutionary Perspective

  109. Career Effects of Mental Health

  110. Personalized machine learning of depressed mood using wearables

  111. No causal associations between childhood family income and subsequent psychiatric disorders, substance misuse and violent crime arrests: a nationwide Finnish study of >650 000 individuals and their siblings

  112. Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions

  113. Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder

  114. Psychedelic-inspired drug discovery using an engineered biosensor

  115. Parental income and mental disorders in children and adolescents: prospective register-based study

  116. A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts

  117. There Is No Evidence That Associations Between Adolescents’ Digital Technology Engagement and Mental Health Problems Have Increased

  118. A ’Trip’ to the Intensive Care Unit: An Intravenous Injection of Psilocybin

  119. Trial of Psilocybin versus Escitalopram for Depression

  120. Parental characteristics and offspring mental health and related outcomes: a systematic review of genetically informative literature

  121. Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence

  122. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials

  123. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

  124. Polygenic burden has broader impact on health, cognition, and socioeconomic outcomes than most rare and high-risk copy number variants

  125. Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender

  126. Genome-wide association analyses of post-traumatic stress disorder and its symptom subdomains in the Million Veteran Program

  127. Predicting Mental Health From Followed Accounts on Twitter

  128. Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

  129. State-dependent responses to intracranial brain stimulation in a patient with depression

  130. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

  131. A non-hallucinogenic psychedelic analogue with therapeutic potential

  132. Combat stress in a small-scale society suggests divergent evolutionary roots for post-traumatic stress disorder symptoms

  133. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types

  134. The Genetic Architecture of Depression in Individuals of East Asian Ancestry: A Genome-Wide Association Study

  135. Growing Up with Grand Theft Auto: A 10-Year Study of Longitudinal Growth of Violent Video Game Play in Adolescents

  136. Antidepressant Response in Major Depressive Disorder: A Genome-wide Association Study

  137. The Comorbidity of Schizophrenia Spectrum and Mood Disorders in Autism Spectrum Disorder

  138. Modafinil Induced Spontaneous Ejaculation Without Orgasm: A Case Report

  139. Common variants contribute to intrinsic human brain functional networks

  140. Increases in Depression, Self-Harm, and Suicide Among US Adolescents After 2012 and Links to Technology Use: Possible Mechanisms

  141. Multivariate GWAS of psychiatric disorders and their cardinal symptoms reveal two dimensions of cross-cutting genetic liabilities

  142. An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression

  143. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial

  144. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review

  145. A unified framework for association and prediction from vertex-wise grey-matter structure

  146. The use of stimulants in depression: Results from a self-controlled register study

  147. GWAS of Depression Phenotypes in the Million Veteran Program and Meta-analysis in More than 1.2 Million Participants Yields 178 Independent Risk Loci

  148. Conditional GWAS analysis to identify disorder-specific SNPs for psychiatric disorders

  149. Encoding, Consolidation, and Renormalization in Depression (ENCORE-D): Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects

  150. The genetic architecture of the human cerebral cortex

  151. Genome-wide Association Study of Creativity Reveals Genetic Overlap With Psychiatric Disorders, Risk Tolerance, and Risky Behaviors

  152. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer

  153. Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples

  154. Machine learning uncovers the most robust self-report predictors of relationship quality across 43 longitudinal couples studies

  155. A large-scale genome-wide association study meta-analysis of cannabis use disorder

  156. The off-prescription use of modafinil: An online survey of perceived risks and benefits

  157. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

  158. Association of Comorbid Mood and Anxiety Disorders With Autism Spectrum Disorder

  159. Under the Weather: As Psychiatrists And Philosophers Begin To Define A Pervasive Mental Health Crisis Triggered By Climate Change, They Ask Who Is Really Sick: The Individual Or Society?

  160. The Relations Among Depression, Cognition, and Brain Volume in Professional Boxers: A Preliminary Examination Using Brief Clinical Measures

  161. Childhood Adoption and Mental Health in Adulthood: The Role of Gene-Environment Correlations and Interactions in the UK Biobank

  162. Are Social Media Ruining Our Lives? A Review of Meta-Analytic Evidence

  163. Depression’s Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome

  164. Bipolar Disorder and ASD

  165. Depression Researchers Rethink Popular Mouse Swim Tests: Animal-Rights Group’s Campaign to End Forced-Swim Tests Comes amid Debate over Whether Method Is Overused

  166. Widespread associations between grey matter structure and the human phenome

  167. Supplement to No Support for Historic Candidate Gene or Candidate Gene-By-Interaction Hypotheses for Major Depression across Multiple Large Samples

  168. Cannabis use, depression and self-harm: phenotypic and genetic relationships

  169. Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders

  170. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions

  171. Multivariate Genome-Wide Analyses of the Well-Being Spectrum

  172. Quantifying Between-Cohort and Between-Sex Genetic Heterogeneity in Major Depressive Disorder

  173. The Neuroactive Potential of the Human Gut Microbiota in Quality of Life and Depression

  174. Anxiety, Depression, and Decision Making: A Computational Perspective

  175. No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples

  176. A systematic study of microdosing psychedelics

  177. Using genetics to examine a general liability to childhood psychopathology

  178. Novel genome-wide associations for suicidality in UK Biobank, genetic correlation with psychiatric disorders and polygenic association with completed suicide

  179. The genetic relationship between female reproductive traits and six psychiatric disorders

  180. The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression

  181. The genetics of the mood disorder spectrum: genome-wide association analyses of over 185,000 cases and 439,000 controls

  182. Cues to mental health from men’s facial appearance

  183. Liraglutide for psychiatric disorders: clinical evidence and challenges

  184. Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?

  185. An evolutionary compass for elucidating selection mechanisms shaping complex traits

  186. The prevalence and co-occurrence of psychiatric conditions among entrepreneurs and their families

  187. Supplementary Online Content for Association of Efficacy of Resistance Exercise Training With Depressive Symptoms: Meta-Analysis and Meta-Regression Analysis of Randomized Clinical Trials

  188. Ketamine Stirs Up Hope—and Controversy—as a Depression Drug: The next big depression treatment might be ketamine, but how best to use it remains unknown

  189. Evolutionary Perspectives on Genetic and Environmental Risk Factors for Psychiatric Disorders

  190. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses

  191. Genome-wide association analyses of chronotype in 697,828 individuals provides new insights into circadian rhythms in humans and links to disease

  192. Looking Through Tinted Glasses: Depression and Social Anxiety Are Related to Both Interpretation Biases and Inflexible Negative Interpretations

  193. Maternal Prenatal Depressive Symptoms and Risk for Early-Life Psychopathology in Offspring: Genetic Analyses in the Norwegian Mother and Child Birth Cohort Study

  194. The Tim Ferriss Show Transcripts: Assessing Risk and Living Without a Rope—Lessons from Alex Honnold (#160)

  195. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

  196. Lithium in drinking water may be negatively associated with depressive temperament in the nonclinical population

  197. Polygenic prediction of the phenome, across ancestry, in emerging adulthood

  198. Common risk variants identified in autism spectrum disorder

  199. Polycystic ovary syndrome, personality, and depression: A twin study

  200. Multi-trait analysis of genome-wide association summary statistics using MTAG

  201. The molecular genetics of participation in the Avon Longitudinal Study of Parents and Children

  202. GWAS Meta-Analysis of Neuroticism (n = 449,484) Identifies Novel Genetic Loci and Pathways

  203. Serotonin and brain function: a tale of two receptors

  204. Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder

  205. 116 independent genetic variants influence the neuroticism personality trait in over 329,000 UK Biobank individuals

  206. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depressive disorder

  207. Genetic contribution to two factors of neuroticism is associated with affluence, better health, and longer life

  208. Psychiatric vulnerability in adults with intellectual disability and autism: A literature review

  209. Genome-wide analysis of 113,968 individuals in UK Biobank identifies 4 loci associated with mood instability

  210. Music-induced analgesia in chronic pain conditions: a systematic review and meta-analysis

  211. Meta-Analysis of the Antidepressant Effects of Acute Sleep Deprivation

  212. Clarifying the Latent Structure and Correlates of Somatic Symptom Distress: A Bifactor Model Approach

  213. The Psychosis Continuum: Testing a Bifactor Model of Psychosis in a General Population Sample

  214. Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study

  215. The Relationship Between Therapist Effects and Therapy Delivery Factors: Therapy Modality, Dosage, and Non-Completion

  216. Forecasting the onset and course of mental illness with Twitter data

  217. Musical prescriptions for mood improvement: An experimental study

  218. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent

  219. Assortative mating and differential fertility by phenotype and genotype across the 20th century

  220. Genetic overlap between schizophrenia and developmental psychopathology: a longitudinal approach applied to common childhood disorders between age 7 and 15 years

  221. Molecular genetic contributions to self-rated health

  222. Genetic contributions to self-reported tiredness

  223. Winners, Losers, Insiders, and Outsiders: Comparing Hierometer and Sociometer Theories of Self-Regard

  224. Neurobehavioral effects of liraglutide and sitagliptin in experimental models

  225. Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (n = 112,151) and 24 GWAS consortia

  226. Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci

  227. Survey Study of Challenging Experiences After Ingesting Psilocybin Mushrooms: Acute and Enduring Positive and Negative Consequences

  228. The Genetic and Environmental Contributions to Internet Use and Associations With Psychopathology: A Twin Study

  229. NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  230. A comparison and integration of structural models of depression and anxiety in a clinical sample: Support for and validation of the tri-level model

  231. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

  232. Beauty in Mind: The Effects of Physical Attractiveness on Psychological Well-Being and Distress

  233. Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway

  234. The Effects of Sleep Continuity Disruption on Positive Mood and Sleep Architecture in Healthy Adults

  235. A rare case of modafinil dependence

  236. Bifactor analysis and construct validity of the five facet mindfulness questionnaire (FFMQ) in non-clinical Spanish samples

  237. The relationship between parental depressive symptoms and offspring psychopathology: evidence from a children-of-twins study and an adoption study

  238. Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials

  239. Mood, anxiety and psychotic phenomena measure a common psychopathological factor

  240. Direct Effect of Sunshine on Suicide

  241. Bipolar disorder and its relation to major psychiatric disorders: a family-based study in the Swedish population

  242. Does Population Density and Neighborhood Deprivation Predict Schizophrenia? A Nationwide Swedish Family-Based Study of 2.4 Million Individuals

  243. The Therapeutic or Prophylactic Effect of Exogenous Melatonin against Depression and Depressive Symptoms: A Systematic Review and Meta-Analysis

  244. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis

  245. EMSAM (deprenyl patch): how a promising antidepressant was underutilized

  246. Transcranial bright light treatment via the ear canals in seasonal affective disorder: a randomized, double-blind dose-response study

  247. Moody melodies: Do they cheer us up? A study of the effect of sad music on mood

  248. PET-PEESE: Meta-regression approximations to reduce publication selection bias

  249. Psychedelics and Mental Health: A Population Study

  250. Examining the role of passive gene-environment correlation in childhood depression using a novel genetically sensitive design

  251. Contribution of Common Genetic Variants to Antidepressant Response

  252. A Bad Case of the Flu? The Comparative Phenomenology of Depression and Somatic Illness

  253. Fecundity of Patients With Schizophrenia, Autism, Bipolar Disorder, Depression, Anorexia Nervosa, or Substance Abuse vs Their Unaffected Siblings

  254. Efficacy of Vitamin D Supplementation in Depression in Adults: a Systematic Review

  255. Positive psychology interventions: a meta-analysis of randomized controlled studies

  256. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

  257. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

  258. Psychiatric Comorbidity and Functioning in a Clinically Referred Population of Adults with Autism Spectrum Disorders: A Comparative Study

  259. Depressive realism: A meta-analytic review

  260. Chronic Dim Light at Night Provokes Reversible Depression-Like Phenotype: Possible Role for TNF

  261. An Exploratory Study of Combination Buspirone and Melatonin SR in Major Depressive Disorder (MDD): A Possible Role for Neurogenesis in Drug Discovery

  262. Interacting with nature improves cognition and affect for individuals with depression

  263. The varieties of inner speech: Links between quality of inner speech and psychopathological variables in a sample of young adults

  264. Back to school blues: Seasonality of youth suicide and the academic calendar

  265. Negative Interpretation Bias in Individuals With Depressive Symptoms

  266. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome

  267. Parent Report of Community Psychiatric Comorbid Diagnoses in Autism Spectrum Disorders

  268. Novel Melatonin-Based Therapies: Potential Advances in the Treatment of Major Depression

  269. Circadian Rhythms, Melatonin and Depression

  270. A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

  271. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial

  272. Physical activity and common mental disorders

  273. Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies

  274. Modafinil Use in patients with a Primary Psychiatric Illness

  275. Shared Genetic Factors in the Co-Occurrence of Symptoms of Depression and Cardiovascular Risk Factors

  276. What’s in a Color? The Unique Human Health Effects of Blue Light

  277. A Randomized Double-Blind Placebo-Controlled Trial of Treatment As Usual plus Exogenous Slow-Release Melatonin (6 Mg) or Placebo for Sleep Disturbance and Depressed Mood

  278. Targacept’s NNR Drugs Rehabilitate Nicotine

  279. 29f34f1bf18ed02b1822cae0355679e4786a193f.pdf

  280. Genetic and environmental influences on the transmission of parental depression to children’s depression and conduct disturbance: an extended Children of Twins study

  281. Vitamin D and depression: where is all the sunshine?

  282. Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression

  283. Placebo interventions for all clinical conditions

  284. Characteristics of children with autism spectrum disorders who received services through community mental health centers

  285. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial

  286. Brief Report: An Autistic Spectrum Subtype Revealed Through Familial Psychopathology Coupled with Cognition in ASD

  287. Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

  288. Resolving the paradox of common, harmful, heritable mental disorders: Which evolutionary genetic models work best?

  289. Episodic psychiatric disorders in teenagers with learning disabilities with and without autism

  290. Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials

  291. A Family History Study of Asperger Syndrome

  292. Neurocognitive Consequences of Sleep Deprivation

  293. 25d2b30bc6ac397258526a43eb5388f60b4809db.pdf

  294. Nicotine as Therapy

  295. A Longitudinal Study of Premorbid IQ Score and Risk of Developing Schizophrenia, Bipolar Disorder, Severe Depression, and Other Non-Affective Psychoses

  296. One Year Follow-Up Study of the Association between Chemical Castration, Sex Hormones, Beta-Amyloid, Memory and Depression in Men

  297. Serum Melatonin and Urinary 6-Sulfatoxymelatonin in Major Depression

  298. Evidence for Early-Childhood, Pan-Developmental Impairment Specific to Schizophreniform Disorder: Results From a Longitudinal Birth Cohort

  299. Evidence-Based Data From Animal and Human Experimental Studies on Pain Relief With Antidepressants: A Structured Review

  300. Modafinil Augmentation of Antidepressant Treatment in Depression

  301. Use of slow-release melatonin in treatment-resistant depression

  302. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment

  303. Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

  304. Depression in Children with Autism/Pervasive Developmental Disorders: A Case-Control Family History Study

  305. Melatonin Treatment of Winter Depression: a Pilot Study

  306. Which is more Productive, Writing in Binge Patterns of Creative Illness or in Moderation?

  307. Circadian Profiles of Melatonin in Melancholic Depressed Patients and Healthy Subjects in Relation to Cortisol Secretion and Sleep

  308. Nocturnal Serum Melatonin Profile in Major Depression in Children and Adolescents

  309. Bedside Stuffed Animals and Borderline Personality

  310. Verbal Creativity, Depression and Alcoholism: An Investigation of 100 American and British Writers

  311. Creativity and Psychopathology a Study of 291 World-Famous Men

  312. Psychiatric Family History And Neurological Disease In Autistic Spectrum Disorders

  313. Violence and the homeless: An epidemiologic study of victimization and aggression

  314. The Lifetime History of Major Depression in Women: Reliability of Diagnosis and Heritability

  315. Psychiatric Disorders in the Parents of Autistic Individuals

  316. The Philosophical Basis of Peer Review and the Suppression of Innovation

  317. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both

  318. Patterns of Melatonin Rhythms in Depression

  319. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects

  320. A Chronobiological Study of Melatonin and Cortisol Secretion in Depressed Subjects: Plasma Melatonin, a Biochemical Marker in Major Depression

  321. Circadian Rhythm of Plasma Melatonin in Endogenous Depression

  322. Parental Death during Childhood and Adult Depression: A Critical Review of the Literature

  323. Abnormal 24 Hour Pattern of Melatonin Secretion in Depression

  324. Negative Effects of Melatonin on Depression

  325. Human Adjustment to an Exotic Environment: The Nuclear Submarine

  326. An Experience in Submarine Psychiatry

  327. A Mega-Analysis of Genome-Wide Association Studies for Major Depressive Disorder

  328. 54e734f25d4f590b32abf9b0deea24c6ced144da.pdf

  329. Mendelsohn 2012

  330. 3d09e10e31d1ac7f14cd287c6a5f336bb73a9836.pdf

  331. Genome-Wide Association Study Identifies Novel Locus for Neuroticism and Shows Polygenic Association With Major Depressive Disorder

  332. Evangelion Creator Hideaki Anno Opens up about His Latest Bout With Depression, Movie Delays

  333. 969fb01231e56ef49f91187a86aa4869cc0dc4af.html

  334. AstraZeneca, Targacept Drug Fails Depression Test

  335. 36e1e12fa5959dbe3a8eaaef5e8e294d215a2b24.html

  336. ...is There Good Evidence of Season Having an Impact on Our Collective Mood? Seasonal Affective Disorder Is Its Own Separate Thing. If You Look at the Evidence on the Population’s Mood, Depression, and Suicide Changing over the Seasons, You Do, in Fact, Find a Glorious Mess.

  337. 18cb0d3d3aa3dbbe6ac8d88ac9b020b5204e71ac.html

  338. What Ketamine Therapy Is Like

  339. 5b3f9eb778066731be9b8a5a52d58f0844e4063f.html

  340. Do Regional Brain Volumes and Major Depressive Disorder Share Genetic Architecture? A Study of Generation Scotland (n = 19,762), UK Biobank (n = 24,048) and the English Longitudinal Study of Ageing (n = 5766)

  341. Incarceration, Polygenic Risk, and Depressive Symptoms among Males in Late Adulthood

  342. The Half-Trillion-Dollar Depression

  343. The Circadian Basis of Winter Depression

  344. The Life-Changing Magic of Mushrooms: A Single Dose of Magic Mushrooms Can Make People With Severe Anxiety and Depression Better for Months, according to a Landmark Pair of New Studies.

  345. 2024-freese-figure2-depressionpolygenicscorepredictionofadverselifeevents.jpg

  346. 2024-freese-figure3-correlationbetweenintuitiveratingofpersonalblameandadverseevents.jpg

  347. 2022-rudolf-figure1-inversecorrelationbetweencountrypercapitagdpandadolescenthappiness.jpg

  348. 2022-rudolf-figure2-positivecorrelationbetweencountrypercapitagdpandadulthappiness.jpg

  349. 2016-saxon-figure1-psychiatrictherapistsrankedworsttobestbymultilevelmodeling.jpg

  350. 2016-saxon-figure4-meantrajectoryofpatientsplitbytherapistgroup.jpg

  351. 2011-hansen-figure3-stabilityofhighschoolsuicideeffectovertime.jpg

  352. https://astralcodexten.substack.com/p/book-review-the-arctic-hysterias

  353. https://forum.effectivealtruism.org/posts/Eq8nwNPNhfXvt2TWj/my-experience-experimenting-with-a-bunch-of-antidepressants

  354. https://hyperboleandahalf.blogspot.com/

  355. https://hyperboleandahalf.blogspot.com/2011/10/adventures-in-depression.html

  356. https://journalnow.com/business/business_news/local/targacept-sale-to-catalyst-is-complete/article_8a0008c4-4dc2-5770-81db-758e527f177b.html

  357. https://medium.com/the-shadow/hot-take-psilocybin-was-the-biggest-mistake-of-my-life-f93cf6598974

  358. https://web.archive.org/web/20220927022638/https://nautil.us/the-man-who-tried-to-redeem-the-world-with-logic-235253/

  359. https://www.afterbabel.com/p/international-mental-illness-part-one

  360. https://www.afterbabel.com/p/social-media-mental-illness-epidemic

  361. https://www.afterbabel.com/p/the-mental-illness-crisis-millenials

  362. https://www.astralcodexten.com/p/ontology-of-psychiatric-conditions-34e

  363. https://www.astralcodexten.com/p/sleep-is-the-mate-of-death

  364. https://www.lesswrong.com/posts/zcYJBTGYtcftxefz9/neural-annealing-toward-a-neural-theory-of-everything

  365. https://www.nature.com/articles/d41586-022-02205-w

  366. https://www.nature.com/articles/s41380-023-02285-8

  367. https://www.nature.com/articles/s41588-023-01596-4

  368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846682/

  369. https://www.nytimes.com/2023/10/21/magazine/climate-anxiety-therapy.html

  370. https://www.nytimes.com/2023/11/03/well/mind/ozempic-weight-loss-antidepressants-antipsychotics.html

  371. https://www.outsideonline.com/outdoor-adventure/climbing/austin-howell-fallen-soloist/

  372. https://www.quantamagazine.org/can-psychedelics-improve-mental-health-20240606/

  373. https://www.quantamagazine.org/what-happens-in-the-brain-to-cause-depression-20240523/

  374. https://www.reddit.com/r/ChatGPT/comments/zsw1jc/i_introduced_my_80_year_old_aunt_to_chatgpt/

  375. 756fb60d13a4b768dd2b12367c19483bb7fb4db3.html

  376. https://www.sciencedirect.com/science/article/pii/S019745561300186X

  377. https://www.scientificamerican.com/article/vitamin-d-supplements-probably-wont-prevent-mental-illness-after-all/

  378. https://www.theatlantic.com/magazine/archive/2023/09/trigger-warnings-feminism-teen-girls-mental-health/674759/

  379. Genetic influences on depression and selection into adverse life experiences

  380. %252Fdoc%252Fpsychiatry%252Fdepression%252F2024-rauf.pdf.html

  381. Enhanced amygdala-cingulate connectivity associates with better mood in both healthy and depressive individuals after sleep deprivation

  382. https%253A%252F%252Fwww.pnas.org%252Fdoi%252F10.1073%252Fpnas.2214505120.html

  383. In-Person Schooling and Youth Suicide: Evidence from School Calendars and Pandemic School Closures

  384. https%253A%252F%252Fwww.nber.org%252Fsystem%252Ffiles%252Fworking_papers%252Fw30795%252Fw30795.pdf.html

  385. On the Randomness of Suicide: An Evolutionary, Clinical Call to Transcend Suicide Risk Assessment

  386. %252Fdoc%252Fpsychiatry%252Fdepression%252F2022-soper.pdf.html

  387. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

  388. https%253A%252F%252Fwww.bmj.com%252Fcontent%252F378%252Fbmj-2021-067606.html

  389. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial

  390. %252Fdoc%252Fpsychiatry%252Fdepression%252F2022-oslin.pdf.html

  391. Is an elevated family-genetic risk for major psychiatric disorders specific to creative occupations?

  392. %252Fdoc%252Fgenetics%252Fheritable%252Fcorrelation%252F2022-kendler-2.pdf.html

  393. Increased global integration in the brain after psilocybin therapy for depression

  394. https%253A%252F%252Fwww.nature.com%252Farticles%252Fs41591-022-01744-z.html

  395. Exome-wide screening identifies novel rare risk variants for major depression disorder

  396. %252Fdoc%252Fpsychiatry%252Fdepression%252F2022-cheng-2.pdf.html

  397. A multi-pronged investigation of option generation using depression, PET and modafinil

  398. %252Fdoc%252Fmodafinil%252F2022-ang.pdf.html

  399. Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study

  400. %252Fdoc%252Fpsychedelic%252Flsd%252F2022-dewit.pdf.html

  401. Structure-based discovery of non-hallucinogenic psychedelic analogs

  402. %252Fdoc%252Fpsychedelic%252Flsd%252F2022-cao.pdf.html

  403. Mental health in people with minority sexual orientations: A meta-analysis of population-based studies

  404. https%253A%252F%252Fonlinelibrary.wiley.com%252Fdoi%252Ffull%252F10.1111%252Facps.13405.html

  405. Increased depressive and anxiety symptoms in non-heterosexual individuals: Moderation by childhood factors using a twin design

  406. %252Fdoc%252Fpsychiatry%252Fdepression%252F2022-oginni.pdf.html

  407. Association Between Homeschooling and Adolescent Sleep Duration and Health During COVID-19 Pandemic High School Closures

  408. https%253A%252F%252Fjamanetwork.com%252Fjournals%252Fjamanetworkopen%252Ffullarticle%252F2787630.html

  409. A systematic review and meta-analysis of the success of blinding in antidepressant RCTs

  410. %252Fdoc%252Fpsychiatry%252Fdepression%252F2022-scott.pdf.html

  411. Parents think—incorrectly—that teaching their children that the world is a bad place is likely best for them

  412. %252Fdoc%252Fsociology%252F2021-clifton.pdf.html

  413. Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth

  414. %252Fdoc%252Fpsychiatry%252Fdepression%252F2021-birmaher.pdf.html

  415. No causal associations between childhood family income and subsequent psychiatric disorders, substance misuse and violent crime arrests: a nationwide Finnish study of >650 000 individuals and their siblings

  416. https%253A%252F%252Facademic.oup.com%252Fije%252Farticle%252F50%252F5%252F1628%252F6288123.html

  417. Parental characteristics and offspring mental health and related outcomes: a systematic review of genetically informative literature

  418. https%253A%252F%252Fwww.nature.com%252Farticles%252Fs41398-021-01300-2.html

  419. Predicting Mental Health From Followed Accounts on Twitter

  420. https%253A%252F%252Fonline.ucpress.edu%252Fcollabra%252Farticle%252F7%252F1%252F18731%252F115925%252FPredicting-Mental-Health-From-Followed-Accounts-on.html

  421. State-dependent responses to intracranial brain stimulation in a patient with depression

  422. %252Fdoc%252Fpsychology%252F2021-scangos.pdf.html

  423. Increases in Depression, Self-Harm, and Suicide Among US Adolescents After 2012 and Links to Technology Use: Possible Mechanisms

  424. https%253A%252F%252Fonlinelibrary.wiley.com%252Fdoi%252Ffull%252F10.1176%252Fappi.prcp.20190015.html

  425. Are Social Media Ruining Our Lives? A Review of Meta-Analytic Evidence

  426. https%253A%252F%252Fjournals.sagepub.com%252Fdoi%252Ffull%252F10.1177%252F1089268019880891.html

  427. Clarifying the Latent Structure and Correlates of Somatic Symptom Distress: A Bifactor Model Approach

  428. %252Fdoc%252Fpsychiatry%252Fdepression%252F2016-witthoft.pdf.html

  429. The Relationship Between Therapist Effects and Therapy Delivery Factors: Therapy Modality, Dosage, and Non-Completion

  430. https%253A%252F%252Fwww.ncbi.nlm.nih.gov%252Fpmc%252Farticles%252FPMC5550525%252F.html

  431. PET-PEESE: Meta-regression approximations to reduce publication selection bias

  432. %252Fdoc%252Fstatistics%252Fmeta-analysis%252F2013-stanley.pdf.html

  433. Back to school blues: Seasonality of youth suicide and the academic calendar

  434. %252Fdoc%252Fpsychiatry%252Fdepression%252F2011-hansen.pdf.html

  435. Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

  436. https%253A%252F%252Fpsychiatryonline.org%252Fdoi%252Ffull%252F10.1176%252Fajp.155.8.1119.html

  437. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects

  438. %252Fdoc%252Fmelatonin%252F1985-brown.pdf.html